GPX1P1 and nasopharyngeal carcinoma: CYP4F24P is significantly downregulated in nasopharyngeal cancer tissues 53, while GPX1P1 is significantly upregulated in nasopharyngeal carcinomas treated with the potential anticancer drug THZ1 54.